Type 2 diabetes-associated variants of the MT 2 melatonin receptor affect distinct modes of signaling.

Autor: Karamitri A; Inserm, U1016, Institut Cochin, Paris, France.; CNRS UMR 8104, Paris, France.; Université Paris Descartes, Paris, France., Plouffe B; Institute for Research in Immunology and Cancer and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Québec H3C 3J7, Canada., Bonnefond A; Université Lille, CNRS UMR 8199-EGID, Institut Pasteur de Lille, Lille, France., Chen M; Inserm, U1016, Institut Cochin, Paris, France.; CNRS UMR 8104, Paris, France.; Université Paris Descartes, Paris, France., Gallion J; Structural Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, TX 77030, USA., Guillaume JL; Inserm, U1016, Institut Cochin, Paris, France.; CNRS UMR 8104, Paris, France.; Université Paris Descartes, Paris, France., Hegron A; Inserm, U1016, Institut Cochin, Paris, France.; CNRS UMR 8104, Paris, France.; Université Paris Descartes, Paris, France., Boissel M; Université Lille, CNRS UMR 8199-EGID, Institut Pasteur de Lille, Lille, France., Canouil M; Université Lille, CNRS UMR 8199-EGID, Institut Pasteur de Lille, Lille, France., Langenberg C; Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK., Wareham NJ; Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK., Le Gouill C; Institute for Research in Immunology and Cancer and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Québec H3C 3J7, Canada., Lukasheva V; Institute for Research in Immunology and Cancer and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Québec H3C 3J7, Canada., Lichtarge O; Structural Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, TX 77030, USA., Froguel P; Université Lille, CNRS UMR 8199-EGID, Institut Pasteur de Lille, Lille, France. ralf.jockers@inserm.fr michel.bouvier@umontreal.ca philippe.froguel@cnrs.fr.; Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, W12 0NN London, UK., Bouvier M; Institute for Research in Immunology and Cancer and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Québec H3C 3J7, Canada. ralf.jockers@inserm.fr michel.bouvier@umontreal.ca philippe.froguel@cnrs.fr., Jockers R; Inserm, U1016, Institut Cochin, Paris, France. ralf.jockers@inserm.fr michel.bouvier@umontreal.ca philippe.froguel@cnrs.fr.; CNRS UMR 8104, Paris, France.; Université Paris Descartes, Paris, France.
Jazyk: angličtina
Zdroj: Science signaling [Sci Signal] 2018 Aug 28; Vol. 11 (545). Date of Electronic Publication: 2018 Aug 28.
DOI: 10.1126/scisignal.aan6622
Abstrakt: Melatonin is produced during the night and regulates sleep and circadian rhythms. Loss-of-function variants in MTNR1B , which encodes the melatonin receptor MT 2 , a G protein-coupled receptor (GPCR), are associated with an increased risk of type 2 diabetes (T2D). To identify specific T2D-associated signaling pathway(s), we profiled the signaling output of 40 MT 2 variants by monitoring spontaneous (ligand-independent) and melatonin-induced activation of multiple signaling effectors. Genetic association analysis showed that defects in the melatonin-induced activation of Gα i1 and Gα z proteins and in spontaneous β-arrestin2 recruitment to MT 2 were the most statistically significantly associated with an increased T2D risk. Computational variant impact prediction by in silico evolutionary lineage analysis strongly correlated with the measured phenotypic effect of each variant, providing a predictive tool for future studies on GPCR variants. Together, this large-scale functional study provides an operational framework for the postgenomic analysis of the multiple GPCR variants present in the human population. The association of T2D risk with signaling pathway-specific defects opens avenues for pathway-specific personalized therapeutic intervention and reveals the potential relevance of MT 2 function during the day, when melatonin is undetectable, but spontaneous activity of the receptor occurs.
(Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
Databáze: MEDLINE
Externí odkaz: